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Autism spectrum disorder (ASD) is a complex devel-
opmental syndrome of unknown etiology. Recent
studies employing exome- and genome-wide
sequencing have identified nine high-confidence
ASD (hcASD) genes. Working from the hypothesis
that ASD-associated mutations in these biologically
pleiotropic genes will disrupt intersecting develop-
mental processes to contribute to a common pheno-
type, we have attempted to identify time periods,
brain regions, and cell types in which these genes
converge. We have constructed coexpression net-
works based on the hcASD ‘‘seed’’ genes, leveraging
a rich expression data set encompassing multiple
human brain regions across human development
and into adulthood. By assessing enrichment of
an independent set of probable ASD (pASD) genes,
derived from the same sequencing studies, we
demonstrate a key point of convergence in midfetal
layer 5/6 cortical projection neurons. This approach
informs when, where, and in what cell types muta-tions in these specific genes may be productively
studied to clarify ASD pathophysiology.INTRODUCTION
Autism spectrum disorders (ASDs) are defined by impairments
in reciprocal social interaction, often accompanied by abnor-
malities in language development as well as repetitive behaviors
and/or restricted interests. Considerable genetic and pheno-
typic heterogeneity has complicated efforts to establish the bio-
logical substrates of the syndrome. However, a sea change is
currently underway in the genetics and genomics of ASD.
Although genome-wide efforts to identify common genetic vari-
ation contributing to the syndrome have not yet led to reproduc-
ible results (State and Levitt, 2011), the identification of the
important contribution of rare de novo mutations (Jamain
et al., 2003; Sanders et al., 2011; Sebat et al., 2007) combined
with high-throughput sequencing technology has recently led
to the systematic discovery of de novo loss of function (LoF) mu-
tations carrying comparatively large biological effects in ASD
(Iossifov et al., 2012; Kong et al., 2012; Neale et al., 2012;
O’Roak et al., 2011, 2012a, 2012b; Sanders et al., 2012). As
a result, the set of associated genes has increased markedlyCell 155, 997–1007, November 21, 2013 ª2013 Elsevier Inc. 997
during the past 18 months, and this number will continue
to grow steadily and predictably as additional cohorts of ASD
families are sequenced (Buxbaum et al., 2012). Moreover, recent
advances are further clarifying the genomic architecture of ASD.
Although de novo point mutations have so far been estimated
to play a contributory role in approximately 15% of affected
individuals, estimates of locus heterogeneity imparted by these
mutations alone already range from several hundred to more
than 1,000 genes (He et al., 2013; Iossifov et al., 2012; Sanders
et al., 2012).
The increasing number of genes carrying rare coding muta-
tions with strong association to the human phenotype presents
unprecedented opportunities for translational neuroscience. At
the same time, the combination of extraordinary locus heteroge-
neity and biological pleiotropy poses considerable obstacles to
the dissection of the pathophysiology of ASD, including the chal-
lenge of designing productive functional studies for a given gene
in the absence of knowing when and where in the brain to inves-
tigate the identified risk mutations. This issue is particularly rele-
vant given the fact that many of the genes discovered to date are
involved in multiple biological processes at multiple points
during development. Moreover, identical mutations in the same
gene can lead to widely disparate psychiatric and neurological
syndromes (Malhotra and Sebat, 2012). Consequently, a deter-
mination of spatiotemporal convergence among groups of
disease-related mutations, all known to lead to ASD, may be
particularly helpful as a first step toward identifying the functional
perturbations specifically relevant for this phenotype.
With this in mind, we have set out to address the key question
of if and when, in what brain regions, and in which cell types spe-
cific groups of ASD-related mutations converge during human
brain development. To pursue this question, we have taken a
‘‘bottom-up’’ approach to gene coexpression network analysis,
focusing initially on only nine ‘‘seed’’ genes carrying multiple de
novo LoFmutations and thereby showing the strongest evidence
for association with ASD. By focusing on these nine ‘‘high-con-
fidence’’ ASD (hcASD) genes, we have sought to minimize the
noise that can accompany network analyses based on inputs
with widely varying evidence for association. Moreover, we
have restricted input genes to those identified only via ‘‘hypoth-
esis-naı¨ve’’ exome- and genome-wide sequencing and have set
a consistent statistical threshold for inclusion, minimizing the
confounds that may accompany attempts to clarify mechanism
using inputs that may have been identified, in part, based on their
biological plausibility.
To evaluate these nine seed genes, we have used spatially and
temporally rich mRNA expression data from developing human
brain as the substrate for constructing networks. This choice is
based on several key considerations: first, that an analysis of
the expression trajectories of ASD-associated genes in typically
developing human brain can provide insight into normal biolog-
ical mechanisms that go awry in ASD (State and Sestan, 2012);
second, that highly correlated gene expression is likely to reflect
shared function and/or regulation; and third, and perhaps most
importantly, that recent work in characterizing the human brain
transcriptome underscores the spatial and temporal dynamism
that occurs during development and provides the ability to
exploit this dimensionality (Kang et al., 2011). These types of998 Cell 155, 997–1007, November 21, 2013 ª2013 Elsevier Inc.data are not yet available for protein-protein interaction and
gene-ontology databases.
To search for points of convergence among spatially and
temporally defined coexpression networks, we relied on a sec-
ond, nonoverlapping set of probable ASD (pASD) genes found
to carry a single de novo LoF mutation and derived from the
same studies as those yielding the hcASD seed genes. This in-
clusion criterion was likewise designed to minimize selection
bias and batch effects and to provide relatively uniform indepen-
dent evidence for association with ASD across this set of inputs.
Our analysis identifies robust, statistically significant evidence
for convergence of the input set of hcASD and pASD risk genes
in glutamatergic projection neurons in layers 5 and 6 of human
midfetal prefrontal and primary motor-somatosensory cortex
(PFC-MSC). Given the extensive genetic and phenotypic hetero-
geneity underlying ASD and the small fraction of risk genes that
we have examined in this study, this likely represents only one of
several such points of convergence. Nonetheless, the analytic
approach presented here clarifies key variables relevant for pro-
ductive functional studies of specific ASD genes carrying LoF
mutations, providing an important step in moving from gene dis-
covery to an actionable understanding of ASD biology.
RESULTS
Identification of hcASD Seed Genes
To identify input genes for this analysis, we have consolidated a
cohort of 1,043 families (599 quartets, 444 trios) from a combina-
tion of published data (987 families; 543 quartets, 444 trios) (Ios-
sifov et al., 2012; Kong et al., 2012; Neale et al., 2012; O’Roak
et al., 2012b) and exome sequencing of an additional 56 quartets
from the Simons Simplex Collection (SSC), a well-characterized
ASD cohort consisting of families with one affected proband, two
unaffected parents, and, in themajority of pedigrees, at least one
unaffected sibling (Fischbach and Lord, 2010). Among the 1,043
probands, 144 de novo LoF mutations were identified (Table S1
available online), with LoF defined as a premature stop codon,
canonical splice-site disruption, or frameshift insertion/deletion.
Within the 599 quartets from the SSC (Iossifov et al., 2012;
Sanders et al., 2012), we observed 75 de novo LoF mutations
in 72 of the affected probands compared to 34 in 32 of the unaf-
fected matched sibling controls (odds ratio [OR] 2.21 95% con-
fidence interval [CI]: 1.45-3.36; p = 53 105, binomial exact test;
Figure S1; Table S1).
Based on this data set, the observation of three de novo LoF
mutations in the same gene in unrelated individuals identifies
an ASD gene (false discovery rate [FDR] q = 0.0002; >99.9%
chance of being a true ASD gene). Moreover, genes with two
or more de novo LoF mutations are also very likely to be true
ASD genes (q = 0.02; 97.8% chance of being a true ASD
gene). Thus, we refer to genes with two or more de novo LoFmu-
tations in unrelated individuals as hcASD genes. Finally, we find
that genes carrying a single de novo LoFmutation aremore likely
than not to be true ASD genes (q = 0.45; 54.7%chance of being a
true ASD gene). We subsequently refer to these as probable
ASD (pASD) genes. Overall, our analysis of the 1,043 families
identifies one previously unreported hcASD gene with two de
novo LoF mutations: Ankyrin 2, neuronal (ANK2); confirms eight
other hcASD genes (Figure 1A); and identifies 122 pASD genes
(Table S1).
Constructing Spatiotemporal Coexpression Networks
To interrogate coexpression dynamics of the nine hcASD genes
in the context of human brain development, we utilized a previ-
ously published spatially and temporally rich transcriptome
data set (Kang et al., 2011) generated as part of the BrainSpan
project. These exon-level expression data originate from 16 re-
gions of the human brain sampled in 57 clinically unremarkable
postmortem brains of diverse ancestry (31 males, 26 females)
that span 15 consecutive periods of neurodevelopment and
adulthood from 5.7 postconceptual weeks (PCW) to 82 years
(Figures 1B and 1C).
To identifyspecific timepointsand regionsofbraindevelopment
relevant to ASD, we partitioned the data into developmental pe-
riods and subsets of brain regions. Temporally, we used a sliding
window of three consecutive time periods across the 15 total
periods, producing 13windows. Spatially, our preliminary analysis
(Figure S2A) suggested that clustering the brain regions based on
transcriptome data from fetal development (period 3–7) would
optimize resolution. Therefore, brain regions with high transcrip-
tional similarity were identified using hierarchical clustering of fetal
transcriptome data. Fourmain clusterswere observed (Figure 2A):
(1) V1C, ITC, IPC, A1C, and STC (V1C-STC cluster); (2) M1C, S1C,
VFC,MFC, DFC, and OFC (prefrontal and primary motor-somato-
sensory cortex or PFC-MSC cluster); (3) STR, HIP, and AMY; and
(4) MD andCBC (MD-CBC cluster). In total, we generated 52 gene
coexpression networks (13 timewindows by four anatomical clus-
ters), corresponding to 52 spatiotemporal windows (Figure 1D).
These networks were created by calculating pairwise Pearson
correlation coefficients between each of the nine hcASD genes
and 16,947 genes from the exon array data set. To focus on the
most relevant coexpression partners, we identified the 20 coex-
pressed genes best correlated to each hcASD gene (Figure 1E)
and having a correlation coefficientR 0.7.
pASD Gene Enrichment Is Localized to Specific
Spatiotemporal Networks
We reasoned that if a particular coexpression network captures
ASD-related biology, then we would expect to see additional
ASD genes mapping within that network. Consequently, to
determine whether any of the 52 spatiotemporal networks
showed convergence of ASD gene expression, we first asked
whether any showed a statistically significant enrichment of
pASD genes (Figure 1F) based on a hypergeometric test.
We identified enrichment of pASD genes in just 4 of the 52 net-
works (Figure 2B), after Bonferroni correction for multiple testing:
PFC-MSC in period 3–5 (10–19 PCW; p = 9.93 106); PFC-MSC
in period 4–6 (13–24 PCW; p = 1.2 3 103); V1C-STC in period
7–9 (24 PCW to 12 months of age; p = 0.02); and MD-CBC in
period 8–10 (birth to 6 years of age; p = 3.5 3 104).
Permutation Testing Highlights Networks Derived from
Midfetal Prefrontal and Primary Motor-Somatosensory
Cortex
Although the hypergeometric test is a computationally efficient
approach to an initial evaluation of enrichment, it assumes thatall genes have an equal chance of being found in the network;
however, the rate of de novo LoF mutations varies with gene
size and GC content, violating this assumption. Moreover, the
correlation-based network construction could potentially lead
to inflated p values. Thus, we conducted separate permutation
tests with 100,000 iterations for each of the four putatively en-
riched networks (Figure 2C). In each iteration, we randomly
selected nine hcASD seed genes, with the probability of seed
gene selection based on gene size and GC content, and then
constructed the corresponding coexpression network using
the identical criteria noted above. We then quantified the pres-
ence of pASD genes within each network and assessed the sig-
nificance of the observed enrichment, correcting for multiple
comparisons. Using this more stringent permutation test (Fig-
ure 2C), pASD enrichment remained in the PFC-MSC networks
at periods 3–5 (p = 0.003) and 4–6 (p = 0.05) and in the MD-
CBC network at period 8–10 (p = 0.04). Enrichment was no
longer observed in the fourth (period 7–9) network. Because
theMD-CBC network had relatively few tissue samples available
compared with the PFC-MSC networks at periods 3–5 and 4–6
(26, 107, and 140 samples, respectively; Figure S2F), we elected
to focus our subsequent analyses on the two PFC-MSC
networks, hereafter referred to as the ‘‘midfetal’’ networks. Addi-
tional permutation tests either varying the number of top coex-
pressed genes chosen or permuting the set of pASD genes
instead of the hcASD genes, as well as a cross-validation exper-
iment and a temporal analysis of individual periods, confirmed
the robustness of our findings (Figures S2C–S2E; Table S2).
The two midfetal networks are displayed in Figures 3A and 3B,
the period 8–10 network is displayed in Figure S3, and network
genes are summarized in Table S3.
The Midfetal Networks Capture Biologically Meaningful
Data
Given the hypothesis that strongly correlated genes share regu-
lation and/or function, we assessedwhether the genes in the two
midfetal networks had greater than expected similarity in their
spatiotemporal expression patterns. As predicted, both the
period 3–5 and 4–6 networks had particularly high correlation
coefficients, reflecting networks more connected than expected
by chance (p = 0.03 and p = 0.02, respectively; Figures 3A
and 3B), suggesting that the genes within these networks are
biologically related.
The most connected hcASD gene within the period showing
the strongest evidence for convergence (period 3–5 network in
PFC-MSC) was T-box, brain, 1 (TBR1), a transcription factor
known to be involved in forebrain development. Consequently,
we assessed the relationship between TBR1 and the other genes
in this network. First, we investigated whether its perturbation
altered expression of other network genes. Using whole mouse
cortex isolated from Tbr1/ and Tbr1+/+ littermates at postnatal
day 0 (P0, equivalent to human early midfetal development;
Workman et al., 2013), we conducted RNA sequencing (RNA-
seq) and identified differentially expressed (DEX) genes (Table
S4). Four of these DEX genes were observed in the network;
NR4A2 and SV2B were both downregulated, whereas FEZF2
and NEFM were both upregulated. Furthermore, all four DEX
genes have previously been identified as TBR1 targets byCell 155, 997–1007, November 21, 2013 ª2013 Elsevier Inc. 999
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Figure 1. Overview of Coexpression Analysis Workflow and Associated Data Sets
(A) Nine hcASD genes derived from our data and additional published data sets. The number of independent de novo LoF mutations identified is indicated in
parentheses. ANK2 is a novel ASD-associated gene.
(B) A comprehensive data set of spatiotemporal gene expression spanning human brain development (Kang et al., 2011) was used to perform coexpression
analysis. This data set spans 12 brain regions during periods 1 and 2 (embryonic and early fetal development) and 16 regions from period 3 to period 15 (early fetal
to late adulthood). Neocortical regions are in red.
(C) Periods of human brain development as defined by Kang et al. (2011). PCW, postconceptual weeks; M, postnatal months; Y, postnatal years.
(D) The hcASD genes (black) are used as ‘‘seeds’’ to build coexpression networks along spatial and temporal dimensions.
(legend continued on next page)
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A B Figure 2. Convergence in Prefrontal
and Primary Motor-Somatosensory Cortex
Regions during Midfetal Development
(A) Hierarchical clustering of brain regions based
on transcriptional similarity during fetal develop-
ment (periods 3–7) divides the brain regions into
four groups, demarcated by color. These clusters
also reflect actual topographical proximity and
functional segregation.
(B) To achieve spatiotemporal resolution, coex-
pression networks were formed from 52 subsets
of the expression data based on 13 develop-
mental stages (in three period windows) and four
sets of brain regions (clusters shown in A). Each
of the networks was tested for enrichment of
122 pASD genes. This heatmap shows the
negative log10(p value) (hypergeometric test) for
enrichment in each network with developmental
stages on the x axis and brain regions on the y
axis. Networks that are not significant are in white;
nominally significant networks are in light red;
networks that are significant after correction for
multiple comparisons are in red with the negative
log10(p value) noted.
(C) pASD gene enrichment is statistically signifi-
cant, after correction for multiple comparisons,
by hypergeometric test (gray line) in the given
regions and time points. Black lines show
p values estimated from the permutation test
based on the number of pASD genes within the
networks (corrected for multiple comparisons);
the vertical red line shows the number of pASD
genes observed for that specific network. pASD enrichment in period 3–5 (p = 0.003), 4–6 (p = 0.05), and 8–10 (p = 0.04) networks remains
significant, whereas the period 7–9 network (p = 0.8) does not.
PFC-MSC, prefrontal cortex and primary motor-somatosensory cortex; V1C-STC, V1C, ITC, IPC, A1C, STC. See also Figure S2 and Table S2.chromatin immunoprecipitation sequencing (ChIP-seq) analysis
in N2A cells (Han et al., 2011). Given the regulatory function of
TBR1 and its prominence in the midfetal networks, we evaluated
if our results were primarily a result of inclusion of this gene. We
found that this was not the case: removal of TBR1 from the coex-
pression analysis did not alter any of our findings regarding
spatiotemporal convergence (Figure S2B).
pASD Genes within Midfetal Networks Are More Likely
to Be Associated with ASD
As noted, we estimate that over half of the 122 pASD genes
represent true ASD risk genes. We consequently hypothesized
that if the midfetal networks effectively capture ASD biology,
then the pASD genes within these networks would show
greater evidence of association with ASD compared to those(E) Mean expression levels for two genes are plotted as a function of period of d
illustrate that highly correlated genes have similar expression profiles across thes
these profiles.
(F) Networks are interrogated for enrichment of an independent set of 122 proba
(G) Networks are tested for enrichment of layer- and cell-type-specific genes.
FC, frontal cerebral wall; PC, parietal cerebral wall; TC, temporal cerebral wall; OC
(periods 3–15); VF, ventral forebrain; MGE, medial ganglionic eminence; LGE, late
DTH, dorsal thalamus; URL, upper (rostral) rhombic lip; OFC, orbital prefrontal co
prefrontal cortex; M1C, primary motor cortex; S1C, primary somatosensory cor
superior temporal cortex; ITC, inferior temporal cortex; V1C, primary visual corte
CBC, cerebellar cortex. See also Figure S1 and Table S1.present in the 100,000 permuted networks. To test this, we
turned to TADA, a newly developed statistical approach that in-
tegrates de novo and inherited variant data with estimates of
gene mutability to yield gene-specific p values (He et al.,
2013). TADA p values for each gene were calculated based
on the whole-exome data in our study as well as case-control
data (935 cases and 870 controls) from the ARRA Autism
Sequencing Consortium study (Liu et al., 2013). Because all
the pASD genes were defined by the presence of a single de
novo LoF mutation, any variability in gene-specific p values
derived from the TADA analysis represents independent evi-
dence for association. Based on 100,000 permutations, we
observed that the TADA p values for pASD genes within both
midfetal networks were significantly lower than expected (Fig-
ures 3C and 3D).evelopment (temporal axis) and region of the brain (spatial axis). The images
e dimensions. The Pearson’s correlation value quantifies the similarity between
ble ASD (pASD) genes (gray).
, occipital cerebral wall; HIP, hippocampal anlage (periods 1–2), hippocampus
ral ganglionic eminence; CGE, caudal ganglionic eminence; DIE, diencephalon;
rtex; DFC, dorsal prefrontal cortex; VFC, ventral prefrontal cortex; MFC, medial
tex; IPC, posterior inferior parietal cortex; A1C, primary auditory cortex; STC,
x; AMY, amygdala; STR, striatum; MD, mediodorsal nucleus of the thalamus;
Cell 155, 997–1007, November 21, 2013 ª2013 Elsevier Inc. 1001
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Figure 3. The Period 3–5 and Period 4–6
PFC-MSC Networks
(A and B) The period 3–5 (A) and period 4–6 (B)
coexpression networks are displayed with the
force-directed layout function of Cytoscape using
correlation as the edge weight (Cline et al., 2007).
Gene coexpression analysis included the 20 genes
best correlated with each hcASDgene. The hcASD
seed genes are in black; pASD genes identified
within the network are in gray; and the top 20
coexpressed genes that are not pASD genes are in
white. The lines (edges) reflect coexpression cor-
relations R 0.7, and the shade represents the
strength of the correlation; positive correlations
are in in red; negative correlations are in blue.
(C and D) The pASD genes enriched within
the networks in (A) and (B) represent those with
the highest probability of being true ASD genes.
The TADA score combines de novo mutation data
with inherited variant data from trios, rare variant
case-control data, and estimates of mutation rate
in order to estimate the probability of ASD asso-
ciation for each gene (He et al., 2013). The
histograms show the results of permutation tests
(100,000 iterations each) assessing the combined
TADA score in the period 3–5 (C) and period 4–6 (D)
networks; the observed scores, shown by the
vertical red lines, are highly significant (p = 6.0 3
105 and p = 2.7 3 104, respectively).
See also Figure S3 and Tables S3 and S4.Human Midfetal Laminar-Specific Expression Data
Implicate Inner Cortical Plate in ASD
Given the well-established variability in gene expression by
cortical layer, we reasoned that spatiotemporal networks identi-
fied in the PFC-MSC would reflect a heterogeneous signal from
multiple layers within each dissection. Consequently, to increase
the resolution of our analysis, we investigated whether the set of
genes present in each midfetal network were more highly corre-
lated within a particular cortical layer than expected by chance.
Therefore, we utilized layer-specific microarray data that were
obtained from laser microdissected (LMD) prenatal human brain
by the BrainSpan Consortium (http://www.brainspan.org). Sam-
ples were derived from frontal neocortex of four brains, corre-
sponding to periods 4, 5, or 6, and each region was dissected
into nine layers, spanning from cortical surface to ventricular sur-
face and including the outer (CPo) and inner (CPi) cortical plate.
To evaluate for layer specificity, we recreated both themidfetal
periods 3–5 and 4–6 coexpression networks within each layer1002 Cell 155, 997–1007, November 21, 2013 ª2013 Elsevier Inc.and assessed each layer-specific
network for increased connectivity. This
approach preserves the overall structure
of the hcASD seed gene networks,
including their temporal properties.
Because many of the hcASD and pASD
genes show expression throughout
developing brain, we hypothesized that
the expression dynamics of the ASD-
related networks would be more informa-
tive than, for example, evaluating differ-ential expression of individual genes. In practice, for each LMD
layer, we calculated the Pearson’s correlation coefficients for
all gene pairs that were found to be present within the midfetal
networks and then summed the coefficients within the layer
to quantify network connectivity. The observed value was as-
sessed using a permutation test and 100,000 iterations.We iden-
tified increased connectivity in a single layer, CPi, for the period
3–5 midfetal network (corrected p = 2.7 3 104; Figures 4A
and 4B; Figure S4).
Mouse Laminar-Specific Expression Data Implicate
Deep Cortical Layers in ASD
Given the role of neuronal migration in early brain development,
we considered whether the observed localization to CPi for
the period 3–5 PFC-MSC network might change over time.
Because the human LMD data were limited to a narrow devel-
opmental interval, we turned to a time series of neocortical
layer-derived RNA-seq data for mouse brain development.
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Figure 4. The PFC-MSC Networks Show
Enrichment for Markers of Deep Layer
Projection Neurons
(A and B) To improve the spatial resolution of the
coexpression analysis, the midfetal networks
were assessed in an independent prenatal tran-
scriptome (http://www.brainspan.org) data set
composed of microarray-based gene expression
profiles of laser microdissected (LMD) human
midfetal (period 4–6) brains. Each hcASD seed
gene network was recreated within each layer
from this LCM data and the significance of the
observed connectivity (sum of correlations along
network connections) for each layer was assessed
by permutation test. The period 3–5 network (A)
shows significant connectivity in the CPi region
(inner cortical plate) corresponding to neocortical
layers 5–6 (corrected p = 2.73 104), whereas the
period 4–6 network (B) is not significantly con-
nected in any layer.
(C) The period 3–5 PFC-MSC network is enriched
for markers of deep layer cells in mouse cortex. At
each postnatal day (P) indicated, differential gene
expression analysis of RNA-seq data was per-
formed on three cortical layers of two mouse
cortices (one male, one female) to identify genes
exclusively differentially expressed in a particular
layer (markers). The ‘‘superficial’’ layer corre-
sponds to the human marginal zone and CPo
(human layer 2 [L2] and L3), layer ‘‘four’’ corre-
sponds to human CPo (human L4), and the ‘‘deep’’
layer corresponds to human CPi and subplate
(human L5/L6 and subplate). From P4 to P10 (mid-
to late fetal development), human orthologs of
murine deep layer marker genes are significantly
enriched in the period 3–5 network (hypergeo-
metric test). From P14 to P180 (adulthood), there is
insufficient resolution to differentiate layers and
none are significantly enriched.
(D and E) Enrichment of a set of previously published cell-type specific marker genes (Kang et al., 2011) is specific to cortical glutamatergic projection neurons
(CPNs) in both midfetal networks (p = 0.02 for period 3–5; p = 0.01 for period 4–6). Markers of deep layer CPNs (L5/L6) are significantly enriched in both networks
(p = 0.02 for period 3–5; p = 0.01 for period 4–6), whereas markers of superficial layer CPNs (L1 to L4) are not. All p values were assessed by permutation test with
100,000 iterations unless otherwise noted.
See also Figure S4 and Tables S5 and S6.These data were composed of two mouse brains, one male and
one female, for each of six time points from P4 to P180 (corre-
sponding in humans to late midfetal development to adulthood;
Workman et al., 2013). At each time point, we sampled three
cortical zones: superficial layers (SL; L1 to L3), layer 4 (L4),
and deep layers (DL; L5/L6) and identified genes that were up-
regulated in only one of these three zones (Table S5). We then
assessed whether a greater than expected enrichment of these
zone-specific genes was observed in the period 3–5 PFC-MSC
network. Consistent with our findings in human fetal cortex,
only deep-layer (L5/L6) markers showed enrichment (p <
0.04, hypergeometric test) and this enrichment was con-
strained to the earlier developmental time points P4 to P10
(equivalent to human late midfetal to late fetal; Figure 4C).
This suggests that our finding of localization to CPi in human
fetal brain for this hcASD-derived network was not a conse-
quence of neurons that ultimately migrate to superficial cortical
layers.Gene-Marker-Based Analysis Implicates Layer 5/6
Glutamatergic Projection Neurons in ASD
Both the human fetal andmouse data localize the period 3–5mid-
fetal network to the deep layers of developing cortex. We next
considered layer- and cell-specific gene markers to add a third,
independent verification of this result and to increase our resolu-
tion to a specific cell type within the cortex. We utilized a previ-
ouslypublishedsetof40markergenes representingfivecell types
and superficial and deep cortical layers in the developing human
brain (Kang et al., 2011; Table S6). We assessed enrichment for
these markers in the midfetal networks using permutation testing
with 100,000 iterations. Significant enrichment was observed for
cortical glutamatergic projection neurons (CPNs) in the period
3–5 and 4–6 networks (3 out of 17 markers in both; p = 0.02 and
p = 0.01 for 3–5 and 4–6, respectively). Further inspection re-
vealed that these threemarkers are specific for deep cortical layer
(L5/L6) CPNs (3 out of 11 in both; p = 0.02andp= 0.01 for 3–5 and
4–6, respectively; Figures 4D and 4E).Cell 155, 997–1007, November 21, 2013 ª2013 Elsevier Inc. 1003
Figure 5. hcASD Genes Are Expressed in Midfetal Deep Layer Projection Neurons
(A) A coronal tissue section through the prefrontal cortex (PFC) and striatum (STR) of a midfetal forebrain was Nissl stained to visualize cells in distinct devel-
opmental zones. The darkest labeled zones are denser with cells, namely the VZ (ventricular zone) and SZi (inner subventricular zone), CPi (inner cortical plate),
and CPo (outer cortical plate). The corresponding adult zones are labeled on the right of the higher magnified boxed area.
(B) Tissue sections of PFC areas at approximately equivalent ages (18–21 PCW) were stained with either antibodies (as labeled on top of the first six columns;
fluorescence in red, green, or blue; DAB in brown) or in situ hybridization probes (last column, SCN2A). Images in the top rowwere taken at the boundary between
CPo and MZ (marginal zone), and images in the bottom row at the boundary between CPi and SP (subplate). Arrows indicate cells colabeled for an hcASD gene
and a marker gene (SATB2 or FOXP2).
SG, subpial granular zone; IZ, intermediate zone; SZo, outer subventricular zone; L, layer; WM, white matter; SE/EL, subependymal/ependymal layer.Expression Profiling Confirms the Expression of hcASD
Genes in Midfetal Cortical Projection Neurons
Our analysis of the ASD-associated midfetal networks predicts
that the majority of the genes within the networks should be ex-
pressed in theCPi inmidfetal prefrontal cortex.We tested this pre-
diction by conducting immunostaining or in situ hybridization in
period 5–6 coronal sections from human frontal cortex for five
representative hcASD genes: TBR1, POGZ, CHD8, and DYRK1A
(immunostaining) and SCN2A (in situ hybridization). As predicted,
all five genes show robust expression in CPi projection neurons of
this tissue (Figure 5). CHD8, DYRK1A, and SCN2Awere observed
in the majority of cortical plate neurons, including projection neu-
rons in CPi and CPo. Consistent with our findings, TBR1, the
most connected gene in our period 3–5 network, is exclusively ex-
pressed in CPi projection neurons in these developmental periods
(Kwanet al., 2012).However,wenote theexpressionofmostother
genes in thenetworks isnotexpected tobe restricted to theCPi, as
the association with this layer was observed at the network level.
To determine localization in different types of CPNs, we per-
formed double immunofluorescent labeling using antibodies
against the proteins encoded by the hcASD genes TBR1 and
POGZ, along with two well-known markers for subtypes of
CPNs, FOXP2 and SATB2 (Kwan et al., 2012). Both TBR1 and
POGZ colocalized with FOXP2, a marker of deep-layer subcor-
tical projection neurons that is exclusively present in the CPi. In
addition, in some CPi neurons, we observed TBR1 and POGZ
colocalizing with SATB2, a marker of intracortical (corticocorti-
cal) projection neurons, indicating that both subgroups of CPi
projection neurons express TBR1 and POGZ.
DISCUSSION
The complexity of the genetic contribution to common neuro-
psychiatric conditions, including ASD, poses ample challenges1004 Cell 155, 997–1007, November 21, 2013 ª2013 Elsevier Inc.for translational neuroscience. We sought to address some of
these challenges by focusing on key questions that other analyt-
ical approaches have been hard pressed to tackle: specifically,
when, where, and in what cell type should a specific ASD-related
mutation or group of mutations be studied to begin to identify
relevant pathophysiological mechanisms?
Given recent studies suggesting that as many as 1,000 genes
or more could contribute to ASD (He et al., 2013; Iossifov et al.,
2012; Sanders et al., 2012), our analysis has uncovered a sur-
prising degree of developmental convergence. Despite starting
with only nine hcASD seed genes, we have identified highly
significant and robust evidence for the contribution of coexpres-
sion networks relevant to L5 and L6 CPNs in two overlapping
periods of midfetal human development (3–5 and 4–6) corre-
sponding to 10–24 PCW. These results strongly support the hy-
pothesis that the marked locus heterogeneity underlying ASD
will point to a much smaller set of underlying pathophysiological
mechanisms.
Although there is clear evidence for the role of synaptic pro-
teins in the pathogenesis of ASD, these findings point to the
contribution of mechanisms extending beyond the synapse
(State and Sestan, 2012). The identification of a functionally
diverse set of risk genes within ASD networks, encoding proteins
that are found in distinct cell compartments, is consistent with
the hypothesis that alterations in multiple distinct pathways or
processes may lead to the ASD phenotype by virtue of their
spatial and temporal properties. For example, the CPi projection
neurons of the midfetal PFC-MSC are among the first cortical
neurons to form synaptic connections, and these early neural
circuits may be particularly vulnerable to a variety of genetic
perturbations and related functional disturbances that may all
ultimately increase the risk for ASD.
To maximize the accuracy of our analysis, we focused consid-
erable attention on the selection of input data. As noted, we
restricted seed genes to those carrying multiple de novo LoF
mutations and pASD genes to those carrying a single de novo
LoF mutation, all derived from the same set of sequencing
studies. Although this excluded several previously identified
and well-established ASD genes, it established statistically
based and consistent inclusion criteria, provided input data
with relatively uniform evidence for involvement in ASD, and
removed any bias introduced by the selection of genes that
may have been originally identified, in part, by mechanistic
hypotheses.
Similarly, although the evidence for vulnerability in some
aspect of development of midfetal CPNs in ASD is quite robust,
there is also support for the notion that additional points of
convergent biology will ultimately be found in ASD. For example,
in addition to midfetal cortical development, we have identified
preliminary evidence for pASD enrichment in thalamus and cere-
bellum during postnatal development. Notably, two previously
well-established ASD genes, NRXN1 and NLGN4X, also are
found within this coexpression network (Figure S3). In a similar
vein, we note that none of the well-established syndromic ASD
genes, suchasFMR1,TSC1,TSC2, orPTEN, are found in the net-
works highlighted by our analyses. Taken together, these find-
ings suggest that additional time points and brain regions are
likely to be identified as both the number of bona fide risk genes
grows and the depth of data on the molecular landscape of hu-
man brain development increases.
In this regard, we note the overall similarities between our
findings and those reported in the accompanying study by Par-
ikshak et al. (2013) in this issue of Cell, which uses an alternative
approach to identify spatial and temporal convergence in genes
involved in neurodevelopmental disorders. They also identify a
potential role of CPNs in ASD, including in midfetal develop-
ment and in L5/L6, yet their results also implicate L2/L3 in
ASD. This difference is unsurprising, given differences in the
input genes selected, in their approach to network/module con-
struction and in their selection of expression data sets. By using
a select small set of hcASD genes, our approach prioritized
specificity over sensitivity, and we fully anticipated there would
be undetected points of temporal and spatial convergence in
ASD risk.
Nonetheless, the findings presented here immediately
constrain important variables in the study of specific ASD-
related mutations and provide the basis to pursue well-informed
hypotheses regarding which mutations in which genes would be
most likely to show overlapping molecular, cellular, or circuit-
level phenotypes. Given the increasing pool of ASD genes and
mutations and the wide range of biological processes the
encoded proteins perform, this ability to focus future in vitro
and in vivo studies on subsets of genes based on their spatial
and temporal properties and network relationships promises to
have considerable value in the pursuit of a deeper understanding
of pathophysiological mechanisms as well as in the identification
of treatment targets.EXPERIMENTAL PROCEDURES
For more details on any of these sections, please see the Extended Experi-
mental Procedures. All experiments involving animals were performed inaccordance with a protocol approved by Yale University’s Committee on
Animal Research.
Exome Data and Mutations
Whole-blood-derived DNA for 56 families chosen at random from the Simons
Simplex Collection was subjected to exon capture using the Nimblegen EZ
Exome V2.0 array and sequenced with 74 bp paired-end reads on the Illumina
HiSeq 2000. Sequence reads were aligned to hg19 using BWA (Li and Durbin,
2009). Single-nucleotide variants were predicted using SAMtools (Li et al.,
2009), whereas insertion-deletions were predicted using local realignment
with Dindel (Albers et al., 2011). All de novo variants were confirmed using
PCR and Sanger sequencing. Additional mutation data were obtained from
the supplemental material from published papers (Iossifov et al., 2012; Kong
et al., 2012;Nealeet al., 2012;O’Roaket al., 2012a, 2012b;Sanderset al., 2012).
Construction of Spatiotemporal Coexpression Networks
Gene-level expression data (Platform GPL5175; Affymetrix GeneChip Human
Exon 1.0 ST Array) were downloaded from the National Center for Biotech-
nology Information (NCBI) Gene Expression Omnibus (GEO accession number
GSE25219) (Kang et al., 2011). Expression data from the core probe set were
used in coexpression analysis (exceptions: for hcASD gene CHD8 and the
pASD genes FLG, FREM3, FRG2C, LMTK3, THSD7A, UBN2, and ZNF594,
data from the extended probe set were utilized). Within each postmortem
brain, gene expression valueswere determined per region, resulting in a vector
of expression values (expression profile) for each gene by brain region and
brain sample. Within each spatiotemporal window, the expression profile
was trimmed to relevant regions and brain samples only, and the Pearson cor-
relation coefficient for the trimmed expression profile was calculated for each
pairwise combination of genes. For each seed gene, the top 20 best-corre-
lated genes with an absolute correlation coefficient with the seed gene of
R0.7 were selected; each network is composed of the hcASD genes and their
top correlated genes. Edges are then formed between any network genes with
absolute correlation coefficientR 0.7. Any hcASD genes without edges were
removed.
Temporal windows were determined solely by creating overlapping sets
of three consecutive periods of development, starting with periods 1–3 and
ending at periods 13–15. To determine spatial windows, brain regions were
grouped according to transcriptional similarity during fetal development
(periods 3–7): based on pairwise Spearman correlations, brain regions were
hierarchically clustered in R using the ‘‘hclust’’ function (1  corr2 as the
distance, clustering using Ward’s method).
Permutation Tests
The permutation tests used throughout are based on selecting nine pseudo-
hcASD seed genes weighted on the likelihood of observing multiple de novo
LoFmutations by chance. A total of 100,000 sets of nine pseudo-hcASD genes
were identified and separate coexpression networks were built for each of the
four networks assessed. These 100,000 networks were used as the basis for
the following permutation tests: pASD gene enrichment, connectivity, TADA
p values, layer-specific marker genes, and cell-type-specific marker genes.
TBR1 KO mRNA-Seq and Data Analysis
Total RNA was isolated from freshly dissected P0 neocortices of a single set of
Tbr1/ and Tbr1+/+ littermates using a QIAGEN RNeasy Mini Kit. Libraries
were prepared using an Illumina mRNA-Seq Sample Prep Kit. Amplified
cDNA was size-selected at 250 bp and validated using the Agilent Bioanalyzer
DNA 1000 system. The final product was subjected to cluster generation using
an Illumina Standard Cluster Generation Kit v4. Libraries were sequenced
to generate 74 bp single-end reads using the Illumina Genome Analyzer
pipeline. Differentially expressed genes were identified based on a jlog2(fold
change)jR 0.5 and adjusted p% 0.05 based on Fisher’s exact test.
Network Analysis with Human Laminar-Specific Expression Data
Region- and layer-specific gene expression data were obtained from the
BrainSpan Prenatal LMD Microarray project. This data set profiles gene
expression in four brains spanning period 4–6 of development (15–21 PCW;
see technical white paper at http://www.brainspan.org). To assess theCell 155, 997–1007, November 21, 2013 ª2013 Elsevier Inc. 1005
relevance of the two networks to each of the nine fetal layers or compartments,
we determined normed Pearson’s correlation coefficients between network
genes connected in the original midfetal networks, using expression data
from each layer separately. By summing these correlations, we were able to
estimate the overall connectivity of the networks layer-by-layer and then to
assess the significance of this connectedness using a permutation test with
100,000 iterations.
Enrichment Analysis in Mouse Neocortical Layers across
Development
Different layers of the mouse cerebral neocortex were microdissected from
live tissue sections of the Dcdc2a-Gfp transgenic reporter mouse (obtained
from the GENSAT project; Schmidt et al., 2013), which expresses GFP selec-
tively in L4 pyramidal and stellate glutamatergic excitatory neurons. Tissue
samples were collected from the primary somatosensory area (equivalent
to human S1C) of mouse brains at P4, P6, P8, P10, P14, and P180. Three
laminar zones were isolated at each time point: superficial layers (SL; L2/
L3 including marginal zone or L1, and pia), L4, and deep layers (DL; L5/L6
including transient subplate zone or adult white matter). At each time point,
genes exclusively upregulated in only one laminar zone (marker genes)
were identified.
Immunostaining and In Situ Hybridization
Coronal sections from 17–20 PCW human frontal cortex were used to validate
the cellular resolution of ASD gene expression. For immunohistochemistry,
sections were pretreated with 0.3% H2O2 followed by incubation in blocking
buffer at room temperature and then incubation for 24–48 hr at 4C in
primary antibodies. Tissue was then incubated with biotin-labeled secondary
antibodies, conjugatedwith avidin-biotin-peroxidase complex (Vector Labora-
tories), and visualized with DAB (Vector Laboratories). Images were taken
using a digital scanner (Aperio ScanScope).
Immunofluorescent staining was performed similarly as aforementioned,
without peroxide pretreatment, and with longer incubations in blocking
buffer, primary and secondary antibodies, and intermittent washes. DAPI
was included during incubation with secondary antibodies to counterstain
nuclei.
For in situ hybridization, brain sections were first mounted on charged
slides, followed by postfixation in 4% paraformaldehyde-PBS and then a
0.1 M triethanolamine with 0.25% acetic anhydride pretreatment. Sections
were then incubated overnight at 65C with 500 ng/ml of digoxigenin
(DIG)-labeled cRNA probes corresponding to human SCN2A nucleotides
1,817–2,954 (NM_001040143). Sections were washed and incubated
overnight at 4C with alkaline phosphatase-conjugated anti-DIG antibodies,
followed by signal detection using NBT/BCIP chromogen (Roche) diluted in
a polyvinyl alcohol (PVA) buffer.
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